Rekombinantni fuzijski dimer domene za vezanje na receptor proteina šiljka virusa sars-cov-2

Classification

1. Anatomical main groupJAnti-infectives for systemic use
2. Therapeutic subgroupJ07
3. Pharmacological subgroupJ07B
4. Chemical subgroupJ07BN
5. Chemical substanceJ07BN04Covid-19, protein subunit

Where it is registered

Each register with its number of medicines and a few of them.

• 🇭🇷Croatia

  HALMED · 1 medicine

  • Bimervax, cjepivo protiv COVID-19 (rekombinantno, adjuvantirano)

All medicines with Rekombinantni fuzijski dimer domene za vezanje na receptor proteina šiljka virusa sars-cov-2

Every register, a page at a time. Strengths and packs are on each medicine’s page.